![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
AstraZeneca PLC on Thursday reported earnings growth, helped by its trusted Oncology portfolio, ahead of a key year f ...
AstraZeneca PLC on Thursday ended a strong year with better-than-expected fourth quarter earnings and said its pipeli ...
AstraZeneca PLC 06 February 2025 AstraZeneca 6 February 2025 Full Year and Q4 2024 results Strong momentum in FY 2024 with Total Revenue and Core EPS up 21% and 19% respectively Revenue...
AstraZeneca PLC 03 February 2025 3 February 2025 Transparency Directive Voting rights and capital The following notification is made in accordance with the UK Financial Conduct...
AstraZeneca PLC is expected to report "industry-leading" sales and earnings per share growth from its portfolio, Bere ...
AstraZeneca PLC on Monday said Imfinzi has been recommended for approval in the EU as monotherapy for limited-stage s ...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 178 | 1.55839607774 | 11422 | 11978 | 10942 | 2586539 | 11350.3022242 | DE |
4 | 620 | 5.64663023679 | 10980 | 11978 | 10578 | 2484179 | 11083.6838341 | DE |
12 | 1486 | 14.692505438 | 10114 | 11978 | 9844 | 2529941 | 10651.4656128 | DE |
26 | -830 | -6.67739340306 | 12430 | 13338 | 9670 | 2341376 | 11175.6214216 | DE |
52 | 996 | 9.39268200679 | 10604 | 13338 | 9461 | 2295457 | 11212.1046925 | DE |
156 | 3363 | 40.8279713488 | 8237 | 13338 | 8214 | 2201244 | 10811.6959176 | DE |
260 | 3871 | 50.0840988485 | 7729 | 13338 | 5871 | 2291522 | 9628.30700651 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions